Clinical Trial Update: Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the efficacy and tolerance of liraglutide for weight loss in obese patients with type 2 diabetes undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodialysis
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Diabetes Mellitus, Type 2, Hemodialysis | Phase 2 | Status: UNKNOWN